United StatesDesignates July 15, 2026 as Glioblastoma Awareness Day
Recognizing this day raises public attention to a deadly brain cancer, may encourage research partnerships, and honors affected patients and families.
What it does
Designates July 15, 2026, as Glioblastoma Awareness Day.
Encourages increased public awareness of glioblastoma and honors those affected.
Supports efforts to develop better treatments and recognizes molecular biomarker testing.
Urges collaborative research among government, private, and nonprofit organizations.
Encourages continued investments in research, including through the Glioblastoma Therapeutics Network.
Argument forRaises public awareness about a deadly and under-recognized cancer, highlighting high incidence and low survival rates.
Argument againstThe resolution is symbolic and non-binding, so it may have little direct effect on funding, clinical care, or research outcomes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Adopted
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 23Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3052; text: CR S3061-3062)Adopted
HealthcareConsumer ProtectionGovernment & Ethics